- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06943638
How Easy-to-Follow Exercises Can Help Cancer Patients With Anxiety While Receiving Chemotherapy
July 31, 2025 updated by: Christine Mavrogiannopoulou
The Effect of Mild Exercise While Receiving Chemotherapy on the Psychology of the Cancer Patient
Cancer is one of the main causes of death, and this study looks at how light exercise and stretching might reduce anxiety in patients receiving chemotherapy.
The research took place in a hospital's daily care unit and used a study design where each patient was compared to themselves, measuring anxiety before and after the exercise program.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kifissia
-
Athens, Kifissia, Greece, 14564
- General Oncological Hospital of Kifisia Oi Agioi Anargyroi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult patients (>18 years old) with cancer receiving chemotherapy
- Signed patient consent
Exclusion Criteria:
- The denial of the patient
- The occurrence of side effects from the treatment (such as dizziness, nausea, severe fatigue)
- Patients with low cognitive level where they could not follow simple instructions
- Patients with hearing disorders that prevented them from following simple instructions
- Patients who could not mobilize independently.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mild exercise and stretching
They received individualized workout and stretching programme to relieve some of the stress
|
For 15 minutes the patient received an individualized mild workout program intending to relax and relieve some of his stress.
The workout includes deep breaths, easy-to-do exercises, and stretches from lying on the bed, sitting in a chair, or standing.
I always followed the patient's tempo and provided him with as many breaks as he needed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Change in the Anxiety Assessment Scale (STAI-State) for Cancer Patients Receiving Chemotherapy Doing Mild Exercises and Stretches
Time Frame: Baseline and approximately 20 minutes post-intervention
|
The STAI-State (Greek version, State-Trait Anxiety Inventory -STAI-) will be used to assess anxiety levels in cancer patients undergoing chemotherapy, before and after a brief exercise intervention.
The STAI-State scale has a 20-item questionnaire where individuals rate how they feel at a particular moment on a scale from "not at all" to "very much so."
"Not at all" equal to 1, "Somewhat" to 2, "Moderately so" to 3, "Very much so" to 4. Scores are submitted and range from 20 to 80, with higher scores indicating greater anxiety.
No subscale is required to compute At baseline (Time = 0 minutes), participants complete the STAI-State scale.
They then engage in a 15-minute mild exercise and stretching program tailored to their physical condition.
In some cases, particularly among younger participants, the session may be conducted in small groups of up to 2 individuals.
Immediately post-intervention (approximately 20 minutes from baseline), participants complete the STAI-State scale again.
|
Baseline and approximately 20 minutes post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Furmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2016 Sep 21;9(9):CD005001. doi: 10.1002/14651858.CD005001.pub3.
- Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL; American College of Sports Medicine. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010 Jul;42(7):1409-26. doi: 10.1249/MSS.0b013e3181e0c112.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 2, 2024
Primary Completion (Actual)
March 24, 2025
Study Completion (Actual)
March 24, 2025
Study Registration Dates
First Submitted
March 24, 2025
First Submitted That Met QC Criteria
April 17, 2025
First Posted (Actual)
April 24, 2025
Study Record Updates
Last Update Posted (Actual)
August 1, 2025
Last Update Submitted That Met QC Criteria
July 31, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 779/15-1-2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
IPD will not be shared because this research doesn't require the reproduction of special types of patients.
They need to have cancer, receive chemotherapy, and be adults.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on Mild Exercise and stretches
-
University of PlymouthCompletedDiabetic Peripheral Neuropathy | Limited Joint Mobility Syndrome | Ankle Joint Range of Motion | Forefoot Peak Plantar Pressure | Foot and Ankle Mobilisations | Home Exercise Programme / StretchesUnited Kingdom
-
University of Kansas Medical CenterActive, not recruiting
-
Dasman Diabetes InstituteCompleted
-
Riphah International UniversityCompleted
-
Maastricht University Medical CenterCompletedObesity | Insulin Resistance | Impaired Glucose Tolerance in ObeseNetherlands
-
Riphah International UniversityCompletedHeart DiseasesPakistan
-
Ottawa Hospital Research InstituteRecruitingType 2 Diabetes (T2DM) | Hypoglycemia (Diabetic)Canada
-
University of Health Sciences LahoreActive, not recruitingWaist Circumference | Abdominal Muscles Strength | Abdominal Muscles Endurance | Abdominal Muscles FlexibilityPakistan
-
Investigación en Hemofilia y FisioterapiaCompletedShoulder Injuries and DisordersSpain